ArticleViruses2020
Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger.
Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 17 citations in OpenAlex.
- Molecular Epidemiology and Genetic Characterization of Feline Panleukopenia Virus among Clinically Suspected Domestic Cats in Tamil Nadu, India.Microorganisms · 2026Article
- Advances in Feline Panleukopenia Virus Vaccines: Immunological Mechanisms, Current Challenges, and Future Perspectives.Viruses · 2026Review
- Molecular epidemiological investigation of viruses in Amur tigers in Northeast China.Archives of virology · 2026Article
- Production of recombinant goose parvovirus origin VP2 protein based on baculovirus expression system.Veterinary research forum : an international quarterly journal · 2026Article
- Virus-like Particle Vaccine for Feline Panleukopenia: Immunogenicity and Protective Efficacy in Cats.Vaccines · 2025Article
- Generation and Immunogenicity of Virus-like Particles Based on the Capsid Protein of a Chinese Epidemic Strain of Feline Panleukopenia Virus.Veterinary sciences · 2025Article
- Feline Panleukopenia Virus ZZ202303 Strain: Molecular Characterization and Structural Implications of theInternational journal of molecular sciences · 2025Article
- Rapid detection of feline parvovirus using RAA-CRISPR/Cas12a-based lateral flow strip and fluorescence.Frontiers in microbiology · 2025Article
- China-origin G1 group isolate FPV072 exhibits higher infectivity and pathogenicity than G2 group isolate FPV027.Frontiers in veterinary science · 2024Article
- The first outbreak of feline panleukopenia virus infection in captive Pallas's cats in Xining Wildlife Park.Frontiers in veterinary science · 2024Article
- Expression of recombinant 35 kDa fragment of VP2 protein of canine parvovirus usingVeterinary world · 2021Article
- Self-assembled raccoon dog parvovirus VP2 protein confers immunity against RDPV disease in raccoon dogs: in vitro and in vivo studies.Virology journal · 2021Article
- Isolation and Genetic Characterization of Canine Parvovirus in a Malayan Tiger.Frontiers in veterinary science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Feline panleukopenia, caused by feline parvovirus (FPV), is a highly infectious disease characterized by leucopenia and hemorrhagic gastroenteritis that severely affects the health of large wild Felidae. In this study, tiger FPV virus-like particles (VLPs) were developed using the baculovirus expression system. The VP2 gene from an infected Siberian tiger (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.